fluocortolone has been researched along with hoe 777 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aliaga, A; Armijo, M; Avila, AL; Balaguer, A; Bravo, J; Del Rio, R; Ferrando, J; Lozano, R; Mascaro, JM; RodrÃguez, M | 1 |
| de Tiedra, A; Lozano, R; Mercadal, J | 1 |
1 review(s) available for fluocortolone and hoe 777
| Article | Year |
|---|---|
Prednicarbate versus fluocortin for inflammatory dermatoses. A cost-effectiveness study.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Cost-Benefit Analysis; Female; Fluocortolone; Glucocorticoids; Humans; Male; Prednisolone; Skin Diseases | 1997 |
2 trial(s) available for fluocortolone and hoe 777
| Article | Year |
|---|---|
Double-blind study of prednicarbate versus fluocortin butyl ester in atopic dermatitis.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Blister; Dermatitis, Atopic; Double-Blind Method; Drug Tolerance; Erythema; Female; Fluocortolone; Follow-Up Studies; Glucocorticoids; Humans; Keratosis; Lichenoid Eruptions; Male; Middle Aged; Ointments; Prednisolone; Pruritus; Remission Induction | 1996 |
Prednicarbate versus fluocortin for inflammatory dermatoses. A cost-effectiveness study.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Cost-Benefit Analysis; Female; Fluocortolone; Glucocorticoids; Humans; Male; Prednisolone; Skin Diseases | 1997 |